Skip to content

Phospholipase A2G1B polymorphisms and risk of colorectal neoplasia

Pancreatic phospholipase A2, product of PLA2G1B, catalyzes the release of fatty acids from dietary phospholipids.Diet is the ultimate source of arachidonic acid in cellular phospholipids, precursor of eicosanoid signaling molecules, linked to inflammation, cell proliferation and colorectal carcinogenesis. We evaluated the association of PLA2G1B tagging single-nucleotide polymorphisms with colorectal neoplasia risk. A linkage-disequilibrium-based tagSNP algorithm (r(2)=0.90, MAF>/=4%) identified three tagSNPs. The SNPs were genotyped on the Illumina platform in three population-based, case-control studies: colon cancer (1424 cases/1780 controls); rectal cancer (583/775); colorectal adenomas (485/578). Evaluating gene-wide associations, principal-component and haplotype analysis were conducted, individual SNPs were evaluated by logistic regression. Two PLA2G1B variants were statistically significantly associated with reduced risk of rectal cancer (rs5637, 3702 G>A Ser98Ser, p-trend=0.03; rs9657930, 1593 C>T, p-trend=0.01); principal component analysis showed that genetic variation in the gene overall was statistically significantly associated with rectal cancer (p=0.02). NSAID users with the rs2070873 variant had a reduced rectal cancer risk (P-inter=0.02). Specific associations were observed with tumor subtypes (TP53/KRAS). The results suggest that genetic polymorphisms in PLA2G1B affect susceptibility to rectal cancer.

Authors: Abbenhardt C; Poole EM; Kulmacz RJ; Xiao L; Curtin K; Galbraith RL; Duggan D; Hsu L; Makar KW; Caan BJ; Koepl L; Owen RW; Scherer D; Carlson CS; Genetics and Epidemiology of Colorectal Cancer Consortium (GECCO) and CCFR; Potter JD; Slattery ML; Ulrich CM

Int J Mol Epidemiol Genet. 2013 Sep 12;4(3):140-9.

PubMed abstract

Explore all studies and publications

Back To Top